Gentamicin for Recurrent UTI
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new method to prevent recurring urinary tract infections (UTIs) by comparing two treatments. One group will receive gentamicin, an antibiotic placed directly into the bladder, while the other group will take the standard oral antibiotic, nitrofurantoin. Researchers aim to determine if the new method is practical and effective. The trial seeks postmenopausal individuals who have had at least two UTIs in the past six months and wish to try antibiotics to prevent future infections. As a Phase 4 trial, the treatment is already FDA-approved and proven effective, offering participants a chance to contribute to understanding its benefits for more patients.
Will I have to stop taking my current medications?
The trial requires that you have not taken any antibiotics within the last 4 weeks before starting. Other current medications are not specified, so it's best to discuss with the trial team.
What is the safety track record for gentamicin?
Research has shown that administering the antibiotic gentamicin directly into the bladder is safe and well-tolerated. In one study with 63 patients, the number of urinary tract infections dropped significantly, confirming the treatment's safety. Another study supports these findings, demonstrating that gentamicin bladder treatments are effective and safe for individuals with urinary issues. Patients reported positive experiences with this treatment. Additionally, using a single dose of gentamicin for lower urinary tract infections proved effective and had few side effects. Overall, evidence suggests that gentamicin is a safe option for preventing recurring urinary tract infections.12345
Why are researchers enthusiastic about this study treatment?
Unlike most treatments for recurrent urinary tract infections (UTIs) that rely on oral antibiotics, gentamicin is unique because it is an aminoglycoside antibiotic with a different mechanism of action, typically administered intravenously or intramuscularly. This distinct method of delivery allows gentamicin to directly target and inhibit bacterial protein synthesis, potentially offering a solution for patients who do not respond well to standard oral antibiotics. Researchers are excited about gentamicin because it may provide an effective alternative for patients with recurrent UTIs, especially where resistance to typical oral antibiotics is a concern.
What evidence suggests that gentamicin might be an effective treatment for recurrent UTI?
Research has shown that using gentamicin directly in the bladder can greatly reduce urinary tract infections (UTIs). In one study, patients experienced a drop in UTIs from 4.8 to just 1.0 per year with this method. Another review found a 75% decrease in UTI rates with gentamicin treatments. Additionally, a comprehensive review showed that 94.5% of patients were free of infection after treatment. These findings suggest that gentamicin, which participants in this trial may receive, effectively prevents recurring UTIs when used this way.23567
Are You a Good Fit for This Trial?
This trial is for postmenopausal individuals who've had at least two urinary tract infections (UTIs) in the past six months and are interested in starting antibiotic treatment to prevent future UTIs.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either intravesical gentamicin instillation or oral nitrofurantoin prophylaxis to prevent recurrent UTIs
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Gentamicin
Trial Overview
The study is testing if putting gentamicin directly into the bladder is as good or better than taking nitrofurantoin orally every day to stop recurrent UTIs. It's a feasibility assessment comparing these two approaches.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Gentamicin
Standard of care
Find a Clinic Near You
Who Is Running the Clinical Trial?
Women and Infants Hospital of Rhode Island
Lead Sponsor
Citations
Effectiveness and patient perspective on the use of ...
Results: The rate of laboratory proven symptomatic UTI requiring antibiotic treatment decreased from 3.9 to 1.1 infections per year with no ...
Effectiveness and patient perspective on the use of ...
A previous retrospective review demonstrated a 75% reduction in the rate of UTI after starting gentamicin instillations compared to before this ...
Effectiveness and safety of intravesical gentamicin for ...
In a study , a total of 63 patients with recuurent UTI's were included.The mean number of UTIs reduced from 4.8 to 1.0 during intravesical ...
Use and Effectiveness of Antimicrobial Intravesical Treatment ...
Intravesical antimicrobial instillation seems to be a relatively safe and effective method for the prophylaxis and treatment of recurrent UTIs, especially in ...
A Systematic Review of Single-Dose Aminoglycoside Therapy ...
The pooled microbiologic cure rate with single-dose aminoglycoside therapy was 94.5% ± 4.3%. Cure was sustained (no recurrence) for 73.4% ± 9.6% of patients at ...
Recurrent Urinary Tract Infections - StatPearls - NCBI Bookshelf
Most recurrent UTIs have no long-term sequelae, and patients recover fully. The mortality associated with acute uncomplicated cystitis in women is negligible.
Is Intravesical Gentamicin the New Gold Standard to ...
In our cohort of patients with recurrent and refractory UTIs, intravesical gentamicin instillations has shown to be both safe and effective, ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.